Magnetic biosensors, based on nanomaterials and miniature electronics, have emerged as a powerful diagnostic platform. Benefiting from the inherently negligible magnetic background of biological objects, magnetic detection is highly selective even in complex biological media. The sensing thus requires minimal sample purification and yet achieves a high signal-to-background contrast. Moreover, magnetic sensors are also well-suited for miniaturization to match the size of biological targets, which enables sensitive detection of rare cells and small amounts of molecular markers. We herein summarize recent advances in magnetic sensing technologies, with an emphasis on clinical applications in point-of-care
I. Introduction
Isolating and detecting sparsely distributed molecular targets, such as circulating tumor cells, DNAs, microvesicles, and soluble proteins, is of great importance for disease monitoring and diagnostics. [1] [2] [3] With recent advances in nanomaterials and microfabrication, various new biosensor platforms have been introduced, promising highly sensitive and selective molecular detection. [4] [5] [6] [7] In these platforms, nanomaterials typically bind to molecular targets and generate distinctive analytical signatures; microfabricated devices could then detect or manipulate labeled targets with spatial and temporal resolution. With the advent of magnetic nanoparticles (MNPs) which can be effectively rendered molecule-specific, magnetism has become an attractive mechanism for bio-separation and biodetection. [8] [9] [10] [11] [12] With recognition ligands conjugated onto their surfaces, MNPs can selectively bind to biological entities of interest, including nucleic acids, proteins, viruses, bacteria, and cells. The binding efficiency is considerably enhanced compared to that of individual recognition ligands, as MNPs provide multiple binding sites (high binding valency). 13 Such magnetically labeled targets can be readily distinguished from the remaining sample constituents, because of the intrinsically low magnetic susceptibility of biological objects. This principle has been extensively applied to MNP-based manipulation and separation. 14 Advances in magnetic sensing technologies (e.g., NMR, various magnetometers) have further allowed for highly sensitive and yet direct detection of MNP-labeled targets even in native biological samples. Magnetic sensing and sorting is particularly well suited to miniaturization and integration into monolithic chips, for use as in integrated point-of-care diagnostic systems. 12, [15] [16] [17] This article reviews the biological applications of magnetic technology. Considering the breadth of the topic, we will focus on magnetic sensing; for magnetic separation technology, we direct the readers to other comprehensive review articles. [18] [19] [20] We will first examine the syntheses and properties of MNPs optimized for biosensing, followed by their labeling methodologies. We will then describe different types of magnetic sensors with their representative biological and clinical applications.
II. Magnetic nanoparticles for biosensing
MNPs are an attractive material for sensing applications because of their unique magnetic properties, facile surface modification, and biocompatibility. 21, 22 Dextran-coated iron oxide nanoparticles, which were synthesized for clinical uses (i.e., contrast agents for magnetic resonance imaging), were initially adopted as a sensing agent. These particles, however, display low magnetization compared to bulk material, which limits the detection sensitivity. Significant efforts thus have been made to devise new synthetic routes to increase particle magnetization. One of the representative methods is the thermal decomposition of metal precursors at high temperature in the presence of organic surfactants. 23, 24 Recent studies further showed enhancement of particle magnetization through the modulation of particle composition (hybrid structure), size and shape. 30 Iron oxide MNPs can also be synthesized by a simple process using iron oleate as a precursor. 24 In this process, iron oleate is prepared by reacting iron chloride with sodium oleate, and uniform MNPs are produced by thermal decomposition of the resulting iron oleate complex. This approach allows large scale synthesis of monodisperse MNPs (up to a 40 g scale in a single batch and without a sizesorting process). The magnetic properties of ferrite particles can be finetuned through metal-doping. Among various ferrite types, manganese (Mn)-doped ferrite (MnFe 2 O 4 ) is known to exhibit high magnetization, due to the high spin quantum number (5/2) of Mn 2+ (Fig. 1a) . 31 It has also been reported that zinc The magnetization of MNPs increases with particle size, since the surface effect (e.g., spin-canting) is reduced in larger particles (Fig. 1b) . 33 For spherical MNPs, the particle
where M s is the saturation magnetization of bulk materials, r is the particle size, and d is the thickness of the magnetically disordered (spin-canting) surface layer. 9 By fitting the experimental data, Jun et al. reported that d ∼ 0.9 nm, which also agreed with the theoretical prediction. The spin-canting effect can be reduced by changing the particle shape. For example, cubic ferrite MNPs have been shown to have higher magnetization than spherical ones with the same magnetic volume, as its cubic geometry allows more spins to align in the same direction on the particle surface (Fig. 1c) . 25, 28 Fe-core MNPs 40 To preserve the existing elemental Fe core, the process grew a crystalline ferrite shell around the core. Moreover, the ferrite shell was metal-doped to further improve particle magnetization. 40 The resulting particles showed negligible oxidation of the Fe core. More importantly, the magnetization values of Fe/MnFe 2 O 4 MNPs were higher (>150%) than those of magnetite-based MNPs (Fig. 1d ).
Multicore MNPs
Although magnetic moments can be enhanced by increasing the size of individual particles, this approach often poses technical challenges; large, single-core MNPs tend to be polydisperse and can spontaneously aggregate in suspension. Controlled clustering of superparamagnetic MNPs was thus developed as an alternative approach to increase the net magnetic moment of particles (Fig. 1e) . [41] [42] [43] For example, MNP-loaded polymer micelles have been synthesized by the self-assembly of MNPs and amphiphilic polymers; in this structure, the as-synthesized hydrophobic MNPs resided in the hydrophobic core of the amphiphilic polymer micelles. Silica is also a widely used matrix to embed MNP clusters. 44, 45 While effectively enhancing the overall magnetic moments of particles, these methods also render them highly soluble in aqueous solution and amenable for surface chemistry.
III. Labeling strategies for molecular sensing
MNP labeling is a critical part of magnetic sensing, which converts molecular information into measurable magnetic signals. For sensitive detection, labeling methods aim to maximally load MNPs onto target molecules. Significant efforts thus have been made to establish 1) optimal coupling chemistries between affinity ligands and MNPs, 2) effective assay configurations for different sensing modalities, and 3) amplification schemes to bind multiple MNPs per target. With such developments, magnetic sensing could be successfully applied to detect a broad range of biological targets, including small molecules, DNAs, viruses, bacteria and mammalian cells.
Conjugation of the affinity ligand to MNPs
The targeting specificity of MNPs is conferred by affinity ligands, which include antibodies, 46 nucleic acids, 47, 48 and small molecules. 49 Several different chemical strategies have been developed to attach affinity ligands to MNPs. 13, 50 One promising approach is the bioorthogonal chemistry termed BOND (bioorthogonal nanoparticle detection). 51 The BOND method uses a rapid, catalyst-free cycloaddition as the coupling mechanism. Antibodies (or other affinity ligands) are modified with trans-cyclooctene and used as scaffolds to couple tetrazine-modified MNPs. This technique is fast, chemoselective, adaptable to other types of nanomaterials, and scalable for biomedical use. Recently, alternative schemes based on complementary oligonucleotide hybridization 48 and cyclodextrin/adamantine supramolecular chemistry 52 have also been developed. Irrespective of the attachment strategies, functionalized MNPs can be used in different assay configurations, as described below.
Clustering assay
In this assay type, MNPs with multivalent affinity ligands bind simultaneously to a single target molecule, which results in particle aggregation (or disaggregation, if the target can disintegrate preformed MNP clusters; Fig. 2a ). Such changes in MNP organization can be detected by either NMR relaxometry 53 or Brownian relaxation measurements. 54 NMR detection measures changes in the transverse relaxation rate (R 2 ) of water protons, caused by MNP clustering; 55, 56 the Brownian relaxation measurements effectively detect changes of the particles' hydrodynamic size. The clustering assay is well-suited for rapid analyses. It does not require washing steps to separate bound MNPs from the free ones; the binding kinetics can be faster than surface-based detection, as the reaction takes place in the entire sample volume. However, since the extent of MNP clustering depends on the quantitative ratio between MNPs and target molecules, the clustering assay often requires extensive optimization to maximize its detection sensitivity. 56 Drawing on its wash-free assay procedure, the clustering assay has been applied to detect small molecules, nucleic acids, and proteins in suspension. 53 
Sandwich magnetic labeling
To detect molecular targets using surface-based sensors, sandwich magnetic labeling is widely used (Fig. 2b) . In this approach, a solid substrate/sensor surface, functionalized with affinity ligands, is used to capture target molecules. This step also effectively increases the local concentration of target molecules and helps to improve the overall assay sensitivity. Captured targets are subsequently coupled with MNPs via secondary affinity ligands. This coupling brings MNPs close to the sensor surface and enables unbound MNPs to be easily washed out. The bound MNPs can be detected using various magnetometers, including magnetoresistance sensors, 57, 58 Hall elements, 59 and microcoils. 60 The method has been successfully applied to detect a range of biological targets, including proteins, nucleic acids and small molecules.
61-64
Direct magnetic labeling
Mammalian cells and bacteria are significantly larger (>several μm) than the commonly used MNPs (often <500 nm). These targets rarely cause clustering of MNPs and often are not amenable to surface immobilization. Instead, the whole organisms can be directly labeled with MNPs (Fig. 2c) . 26, 27, 65 The size difference between target cells and MNPs also allows for easy removal of unbound particles, which significantly increases the overall detection sensitivity. To improve the performance of this targeting assay, and to provide a modular approach for magnetic labeling, the BOND strategy has been adopted for cellular targeting. 51 In this method, cells are first targeted with affinity ligands modified with a molecular tag and subsequently coupled with MNPs. Compared to using ligand-MNP direct conjugates, the two-step labeling generally reduces the required amount of affinity ligands (e.g., antibodies) by more than 10-fold, allows for the use of generic MNPs for a range of different molecular targets, and importantly, improves MNP-loading to target molecules through multiple attachments of MNPs per affinity ligand. 66 
Magnetic amplification
Following the initial labeling with MNPs, multiple magnetic layers can be formed by sequentially applying MNPs conjugated with orthogonal binding partners. 48, 67 This scheme amplifies the magnetic signal with each round of labeling, thereby improving the overall detection sensitivity. In one example, Liong et al. employed sequence-specific DNA hybridization to increase the number of MNPs loaded onto cells (Fig. 2d) . 48 The method was repeated up to 20 rounds of MNP layering, leading to >15-fold enhancement of the signal from the initial targeting.
IV. Magnetometers for signal detection
Various types of magnetometers can be used to measure the magnetic signal from the labeled biological objects. The detection method could be classified into two groups, namely volumetric and surface-based sensing. In volumetric sensing, the analytical signal is generated from the entire sample volume, which often makes the detection assays simple and fast. The sensing resolution, however, can be limited by the ensemble average nature of signal acquisition. Nuclear magnetic resonance (NMR), magnetic susceptometry, and conventional SQUID (superconducting quantum interference device) magnetometry are representative examples of volumetric sensing. Surface-based sensors, on the other hand, are complementary to the volumetric ones. By directly detecting individual magnetic objects, surface sensors can achieve higher sensitivity and resolution. A drawback of this sensing mechanism is the requirement to bring or bind target samples to the sensing elements; this could make assays time-consuming and more involved in the device structure. Several solid state magnetometers (e.g., magnetoresistance sensors, Hall effect sensors) have been adopted as a surfacebased biosensor.
Miniaturized NMR system
NMR indirectly detects magnetically-labeled objects through the measurement of 1 H proton signals. When placed in polarizing NMR magnetic fields, MNPs generate local dipole fields, which efficiently destroy the coherence in the spin-spin relaxation of water protons. Samples containing MNP-labeled objects consequently display higher transverse relaxation rate (R 2 ) than non-targeted ones (Fig. 3a) . 68 This detection scheme benefits from a built-in signal amplification, since each MNP affects more than millions of surrounding water molecules. 69 Significant advances have been made to facilitate NMR-based magnetic detection. These efforts include designing a new permanent magnet assembly for NMR field generation, 70 integrating an NMR transceiver into a customdesigned chip, 71 and miniaturizing NMR probes. 27, 72, 73 Such miniaturized NMR (μNMR) systems not only allow for The microcoil is embedded in a polymer (polydimethylsiloxane/PDMS) block with the entire coil-bore accessible, and a thin-walled tube is used for sample loading. 16 (d) The NMR electronics is designed for standalone operation and high programmability. (e) A multifunctional fluidic cartridge was developed for bacterial detection. 81 The device integrates polymerase-chain-reaction (PCR) chambers, torque-assisted valves, mixing channels and a microcoil. Bacterial samples, PCR reagents, microbeads, and MNPs are loaded onto the chip. After on-chip PCR, magnetic labeling of the microbeads takes place along the mixing channel. The magnetically labeled beads are then purified and concentrated into the μNMR probe (microcoil) by the membrane filter. portable operation but also have higher mass sensitivity. The most recent μNMR system (Fig. 3b) has been further optimized for user-friendly operation in clinical settings. Disposable thin-walled (thickness 25 μm) tubes were used to minimize system contamination as well as to simplify the sample-loading process (Fig. 3c) . The designed electronics were programmable for versatile NMR measurements (Fig. 3d) . Importantly, it automatically compensated for drifts in NMR frequency caused by environmental temperature fluctuation, thereby ensuring reliable measurements in clinical settings. The system also interfaced with a mobile device for easy use by medical personnel and for data logging/sharing via a wireless connection. The developed system has been applied in numerous clinical trials, including circulating tumor cell detection, [74] [75] [76] bacterial profiling, [77] [78] [79] and blood-quality monitoring. 80 The capacity of the μNMR device can also be improved through integration with microfluidics. For example, Liong et al. demonstrated a μNMR-fluidic cartridge for bacterial detection (Fig. 3e) . 81 The device performed multifunctions on-chip:
target DNA was amplified via polymerase chain reaction (PCR); amplicons were captured onto microbeads and subsequently labeled with MNPs; and the labeled microbeads were concentrated into the NMR probe region. Such integration enabled fast, streamlined assays with the entire reaction completed within 2.5 hours and also prevented crosscontamination of PCR-amplified products. This platform was used to detect Mycobacterium tuberculosis (MTB) in patient samples (Fig. 3f) and to identify drug-resistant MTB strains. 81 
Magnetic susceptometry
Magnetic susceptometry measures the volumetric responses of MNPs under external magnetic field excitation. Compared to NMR measurement, this approach has a simpler setup, particularly because it does not require a highly uniform magnetic field. Furthermore, direct measurement of the MNPs can permit simultaneous detection of different types of MNPs. 82 Susceptometry, however, has a lower sensitivity than NMR-based detection, due to its lack of an inherent signal amplification mechanism. A widely used detection scheme is based on Brownian relaxation. 82, 83 Each MNP in suspension undergoes thermal rotation at a timescale (τ B ) proportional to the particle hydrodynamic volume. Such thermal rotation affects the frequency-dependent magnetic susceptibility (χ) of MNPs; the quadrant component of χ has its peak at the excitation frequency of 1/τ B . Binding of target molecules to MNPs changes the hydrodynamic diameter (and hence τ B ) and induces a shift in the peak position. Magnetic susceptometry has been used to detect soluble proteins, 84 DNA, 82 and bacteria, 85 with signals measured via induction coils or SQUID. Recently, Park et al. demonstrated a compact susceptometer for Brownian relaxation measurement (Fig. 4a) . 54 Multiple types of MNPs could be differentiated in a mixture according to their hydrodynamic size (Fig. 4b) , wherein the susceptibility spectrum was employed as a unique Brownian relaxation signature. As a model biological application, biotinylated horseradish peroxidase was detected through the clustering assay with streptavidincoated MNPs.
Magnetoresistance sensors
Magnetoresistance (MR) sensors are electrical resistors whose resistance changes under the influence of external magnetic fields. This MR effect is caused by the spin-orbit coupling between conduction electrons and magnetic layers. A representative example is the giant magnetoresistance (GMR). The phenomenon takes place in a magnetic structure consisting of ferromagnetic layers separated by non-magnetic metallic layers (Fig. 5a) ; the relative changes between the layer magnetization significantly affects the overall electrical resistance (Fig. 5b) . For biosensing applications, GMR sensors operate in conjunction with the magnetic sandwich assay, wherein target molecules are captured onto the ligandfunctionalized sensor surface, and subsequently tagged with magnetic probes. One of the first GMR-based sensors used micrometer-scale magnetic beads for labeling. 86 The large size difference between the magnetic probes and the detection targets, however, limited the assay speed and sensitivity. 62 By employing MNPs, Osterfeld et al. overcame such challenges and demonstrated sensitive and real-time protein sensing. 62 The system was further improved to detect sparse molecular targets in complex biological samples. 64 Multiplexed protein detection was also demonstrated with an 8 × 8 sensor array, wherein each GMR sensor was functionalized with different antibodies. These sensors showed a linear dynamic range of over six orders of magnitude, with a limit of detection of ∼50 aM. 64 Beyond protein detection, the MR-based sensors have been further applied to detect specific DNA sequences 87 as well as magnetically labeled cells. 88, 89 More recently, a hybrid GMR system was implemented by combining two separate chips, namely a 256 GMR array and a custom-designed integrated circuit (IC) chip for signal processing (Fig. 5c) . 90 With such a large array of sensors, this system could function as a protein microarray with the capability to monitor real-time kinetics. The performance of the chip was characterized by detecting an ovarian cancer biomarker, with signals detected at concentrations down to 10 fM.
Miniaturized Hall sensors
The classical Hall effect refers to the generation of a voltage difference in an electrical conductor subjected to a magnetic field. The phenomenon arises as the moving charge carriers, deflected by Lorentz force, accumulate on one side of the conductor. While Hall sensors generally have a lower field sensitivity than MR-based sensors, they can assume signal linearity even at high magnetic fields (>2 T). This attribute makes it possible to use large magnetic fields that fully magnetize MNPs. Furthermore, sensor fabrication is compatible with the IC process, enabling monolithic integration of large sensor arrays with control electronics. Micrometer-scale Hall (μHall) sensors have been used to detect magneticallylabeled molecular targets. 61, [91] [92] [93] Recently, Gambini et al.
significantly advanced the platform by implementing large arrays of μHall sensors (64 × 160 Hall elements) using complementary metal-oxide-semiconductor (CMOS) technology (Fig. 6a) . The chip also integrated parallel readout circuitry for high throughput detection and local microelectromagnets for controlled polarization of magnetic beads (Fig. 6b) . In its operation, the system measured the decaying remnant field of magnetic beads immediately after the magnetization field was turned off (Fig. 6c) . 94 This approach enabled the weak field that arises from the magnetized bead to be separated from a much stronger applied field (10 2 to 10 5 times larger), thereby improving detection sensitivity.
In the titration measurement with the magnetic beads (Dynabead M280, Invitrogen), the sensor could determine the bead concentration with an uncertainty (1σ) of 25 particles per array, or equivalently a 0.1% coverage of the sensing area (0.64 mm 2 ) (Fig. 6d) . 95 Introducing a new application of the μHall technology, Issadore et al. used the sensor to detect magnetically labeled cells in flow (magnetocytometry). 96 Target cells were labeled with MNPs, and the resulting magnetic fields from these cells were measured by a μHall element that reported an electrical voltage (V H ) proportional to MNP counts per cell (Fig. 7a) .
Because the sensor measures transient signal from moving cells, it could operate in an alternate-current (AC)-coupling mode, unaffected by the static magnetic field (B 0 ) used to magnetize MNPs. The sensor chip had an eight 8 × 8 μm 2 μHall elements arranged into an overlapping 2 × 4 array (Fig. 7b) , which ensured that individual cells pass directly over at least two μHall elements. Hydrodynamic focusing was also used to stream cells onto the sensing area. 96 When compared with conventional flow cytometry, the μHall platform showed good agreement in molecularly screening cells (Fig. 7c) . Importantly, the sensor was able to detect individual cells even in the presence of vast numbers of blood cells and unbound reactants. This capability made the platform wellsuited for rare cell detection in complex biological media. For example, in a clinical trial with cancer patient samples, the μHall displayed much higher sensitivity in detecting circulating tumor cells than the clinical standard method (Fig. 7d) .
Diamond magnetometer
Nitrogen-vacancy (NV) center diamonds have recently emerged as a promising new technology for highly sensitive magnetic detection. [97] [98] [99] [100] The NV center is formed when a nitrogen atom replaces a carbon atom in the diamond crystal lattice and a vacancy adjoins in one of the four neighboring sites (Fig. 8a) . The center has a spin-triplet ground state with sublevels, m s = 0 and ±1. In the absence of an external field, the m s = 0 state is spontaneously split from m s = ±1 (zero-field splitting), with an energy gap of 2.87 GHz. In the presence of an external field (B 0 ), the energy levels of m s = ±1 further split due to the Zeeman effect (Fig. 8b ). These energy levels can be detected by applying microwave excitation to the system and concurrently performing fluorescence measurements. By spectroscopically probing the energy levels of m s , the field strength (B 0 ) can be determined with high precision. NV diamond sensors have significant potential for biosensing. They can achieve excellent detection sensitivity (3nT/√Hz) 98 and operate at room temperature. Standard microscopy can be used to generate wide-field images of magnetic fields at a nanoscale resolution. For example, Le Sage et al. demonstrated magnetic imaging of magnetotactic bacteria with a NV diamond sensor (Fig. 8c) . 101 Magnetic fields, created by chains of magnetosomes inside the bacteria, were measured, and their full vector map was reconstructed at a sub-cellular spatial resolution (400 nm) in a field of view of 100 μm 2 . More recently, the NV diamond sensor has also been used as a NMR reader. 102, 103 The exquisite sensitivity of the NV diamond detected NMR signals from 10 4 nuclear spins, enabling NMR measurements on the nanometer scale samples.
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V. Conclusions and future perspectives
Magnetic biosensor is a promising technology for fast and sensitive molecular diagnostics. A key advantage of magnetic sensing is its intrinsically low background noise in biological media. Robust assays can thus be performed with minimal purification steps, thereby reducing sample loss and potential degradation of molecular markers. As a synergistic platform, magnetic sensing draws on complementary advantages from multiple disciplines to expand its target versatility and detection functionality. The advances in nanomaterials and sensing technologies, as described in this review, have enabled significant strides towards expanding the reach of magnetic biosensors for a wide range of biological targets and implementing platforms for practical uses in clinical settings. A major challenge in magnetic detection is to develop a technique for simultaneous detection of multiple (i.e. dozens to hundreds) biomarkers. Magnetic sensors have a limited capacity for multiplexed detection, because the signal arises from a single parameter (e.g., magnetic moment, relaxation time). Different approaches have been explored to address this limitation. For example, Liong et al. sequentially labeled different molecular markers with MNPs and measured accumulative magnetic signals; the signal difference between consecutive labeling steps correlated with the level of the target marker expression. 48 Microfabricated magnetic structures with distinct spectral signatures have been demonstrated as multispectral contrast agents for magnetic resonance imaging. 104 The non-linear magnetization of MNPs has also been exploited to distinguish differently sized particles by measuring magnetic moments at varying static magnetic field. 96 These methods, albeit promising, still need to be optimized for robustness and extended beyond their current 3-4 biomarker limits. Another appealing direction is to further integrate multiple sensors and magnetic actuators into a single device, so as to empower the platform for more complex, multi-step tasks. Incorporating a large number of sensors and their control circuits into a single device is one promising approach. Such devices will effectively function as a magnetic "imager" with a large field-of-view. This scheme will render the system simple-tooperate without the need for complex microfluidics and significantly enhance the assay speed through parallel measurements. Such developments will facilitate advances towards the "sample-to-answer" platform, wherein the native clinical specimen is the device input and the electronic data, presented in a useful format for clinicians, is the device output. 
